Related Experiment Video
Updated: May 5, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Disseminated BCGosis After Intravesical BCG Installation for Bladder Cancer
Tyler Martinson1, C Bradley Hare2, Andrea Kirmaier3
1Department of Internal Medicine, Kaiser Permanente, San Francisco, California, USA.
Abstract:
We present three patients who developed BCGosis, a rare complication following intravesical Bacillus Calmette-Guérin (BCG) treatment for bladder cancer. These cases highlight the diverse clinical manifestations, diagnostic challenges, and management strategies of this entity, emphasizing the importance of early recognition and initiation of antimycobacterial treatment.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016